Clinical Trials Logo

Clinical Trial Details — Status: Completed

Administrative data

NCT number NCT03905551
Other study ID # 921-5/11/2014
Secondary ID
Status Completed
Phase N/A
First received
Last updated
Start date February 1, 2015
Est. completion date February 28, 2020

Study information

Verified date September 2021
Source University of Thessaly
Contact n/a
Is FDA regulated No
Health authority
Study type Interventional

Clinical Trial Summary

Despite the tremendous advances in dialysis technology, hemodialysis (HD) is a significant challenge for dialysis patients and quality of their lives[2]. Research has shown for years that dialysate fluid temperature and especially the typical dialysis (TD) temperature at (37°C) are complicated by hemodynamic instability which leading to an increased risk of heat-induced hypotension causing patient discomfort and increased mortality. Cold dialysis (CD) is defined as the reduction of dialysis fluid temperature to 35-36°C, approximately 1°C below the typical dialysate temperature which ranges between 37-38°C. A number of studies have reported beneficial effects of CD on maintaining hemodynamic stability, minimizes hypotension and exerts a protective effect over major organs including the heart and brain. In addition, current evidence showed the protective effect of CD in cardiac performance during the dialysis session. As the investigators know until today cardiovascular mortality is an important issue for nephrologists that care for ESRD patients, however, many other benefits have been observed on patients' overall health and quality of life levels by used of CD. The above-mentioned benefits of CD in the hemodynamic stability and the general quality of life of the patients are highlighted even further due to the ever-increasing adoption of intradialytic exercise programs. It has been well established that intradialytic exercise leads to benefits of physiological, functional, and psychological deterioration, which commonly accrues as a consequence of biological aging, catabolic illness, and a sedentary lifestyle, factors that may all contribute to the progressive decline of vitality and quality of life commonly observed in ESRD patients. However, despite a strong rationale for the implementation of intradialytic exercise programs and the aforementioned benefits of CD, the separate and combined effects of these protocols in aspects related to quality of life and health in ESRD patients have not been investigated to date. The aim of the current clinical study was to assess the effect of exercise rehabilitation regimes in combination with changes in dialysate temperature in aspects related to quality of life and health in end-stage renal disease patients receiving hemodialysis.


Description:

The primary aim of the clinical study was to investigate the combined effect of cold dialysis and aerobic exercise in aspects related to health. More specific: 1. To investigate the thermoregulatory responses of hemodialysis patients under four different hemodialysis protocols. 2. To assess the changes in muscular architecture and functional capacity in dialysis patients after 7 months of intradialytic exercise training. 3. To assess the impact on insulin sensitivity and glucose disposal.


Recruitment information / eligibility

Status Completed
Enrollment 72
Est. completion date February 28, 2020
Est. primary completion date June 29, 2018
Accepts healthy volunteers No
Gender All
Age group 18 Years and older
Eligibility Inclusion Criteria: - Clinically stable ESRD patients receiving regular hemodialysis treatment for at least 3 months, - adequate dialysis delivery Kt/V >1.1 - good compliance of dialysis treatment - serum albumin >2.5 g/dL - hemoglobin =11g/dL. Exclusion Criteria: - Patients with a reason to be in a catabolic state, - hyperthyroidism, - active vasculitis, - malignancies, - pregnancy - HIV, - opportunistic infections, - musculoskeletal contraindication to exercise, - requirement for systemic anticoagulation, - participant or participated in an investigational drug or medical device study within 30 days, - active inflammations, that required intravenous antibiotics within 3 months prior to enrollment, - diabetics receiving insulin therapy, - New York Heart Association grade IV heart failure, - mental incapacity to consent.

Study Design


Related Conditions & MeSH terms


Intervention

Procedure:
Cold Dialysis
Dialysate temperature reduced to 35oC for a period of 7 months.
Typical Dialysis
Dialysate temperature is set at 37oC for a period of 7 months
Exercise
Aerobic Intradialytic exercise training

Locations

Country Name City State
Greece Patsidis General Clinic Larissa Thessaly
Greece University Hospital of Larissa, Nephrology Clinic Larissa Thessaly
Greece General Hospital of Trikala Trikala Thessaly

Sponsors (2)

Lead Sponsor Collaborator
University of Thessaly National and Kapodistrian University of Athens

Country where clinical trial is conducted

Greece, 

References & Publications (2)

Krase AA, Flouris AD, Karatzaferi C, Giannaki CD, Stefanidis I, Sakkas GK. Separate and combined effects of cold dialysis and intradialytic exercise on the thermoregulatory responses of hemodialysis patients: a randomized-cross-over study. BMC Nephrol. 2020 Dec 2;21(1):524. doi: 10.1186/s12882-020-02167-z. — View Citation

Parnas I, Spira M, Werman R, Bergmann F. Micro-electrode studies of the giant fibres of the American cockroach. Electroencephalogr Clin Neurophysiol. 1969 Aug;27(2):221. — View Citation

Outcome

Type Measure Description Time frame Safety issue
Primary Change in Body Heat Storage Body Heat storage will be assessed during the 4 hours of dialysis under the two main conditions. Body Heat Storage is calculated in Watt Changes from baseline at 7 months
Primary Change in Insulin Resistance Insulin resistances will be assessed by an Oral Glucose Tolerance Test using the OGIS index Changes from baseline at 7 months
Primary Change in Muscle Size Muscle size will be assessed using Ultrasonography Changes from baseline at 7 months
Secondary Change in Quality of life score Quality of life will be assessed using the Sort Form 36 questionnaire. The Short Form (36) Health Survey is a 36-item, patient-reported survey of patient health. The SF-36 is a measure of health status and is consisted of eight scaled scores, which are the weighted sums of the questions in their section. Each scale is directly transformed into a 0-100 scale on the assumption that each question carries equal weight. The lower the score the more disability. The higher the score the less disability i.e., a score of zero is equivalent to maximum disability and a score of 100 is equivalent to no disability.
The eight sections are:
vitality
physical functioning
bodily pain
general health perceptions
physical role functioning
emotional role functioning
social role functioning
mental health
Changes from baseline at 7 months
Secondary Change in Functional Capacity Functional capacity will be assessed by the 6 min walking test Changes from baseline at 7 months
Secondary Change in Daily Physical activity Daily physical activity will be assessed by a 7 day recall pedometer Changes from baseline at 7 months
See also
  Status Clinical Trial Phase
Completed NCT04103177 - Physical Activity in Haemodialysis Patients: a Feasibility Study N/A
Completed NCT01561118 - DiaSport - Endurance-orientated Training Program With Children and Adolescents on Maintenance Hemodialysis N/A
Withdrawn NCT03645720 - The Prognosis of Graft Using Plastic Cannula in Hemodialysis N/A
Active, not recruiting NCT02598635 - Effects of Cholecalciferol on Osteoprotegerin Levels in Patients on Peritoneal Dialysis Phase 4
Terminated NCT01643733 - Study on Fistuloplasty Using Flow Measurement Guidance N/A
Not yet recruiting NCT03169400 - Theranova Dialyzer and Chronic Kidney Disease - Mineral Bone Disorder (CKD-MBD) N/A
Completed NCT02439697 - A Cohort Study of Conversion From Aranesp® to NESP® for the Treatment of Anemia in Dialysis Patients N/A
Completed NCT02063490 - Nurse-led Intervention to Improve Phosphate Binder Adherence N/A
Completed NCT04106310 - Theranova vs High-flux HD Comparison N/A
Recruiting NCT06056102 - CAR-T Cell Therapy for Desensitization in Kidney Transplantation Phase 1
Completed NCT04698512 - MAgicTouchâ„¢ Intervention Leap for Dialysis Access (MATILDA) Trial
Completed NCT02819011 - OHI--Randomized Control Trial to Evaluate Efficacy, Acceptability, and Perception of Benefit of an Innovative Custom AFO Phase 2
Completed NCT02484118 - Hemodialysis Blood Flow and Urea Clearance N/A
Enrolling by invitation NCT01641757 - Effect of Non-Surgical Periodontal Therapy on Serum Albumin Levels of Patients on Maintenance Hemodialysis Therapy, Phase 2
Completed NCT03172039 - Antimicrobial Use and Stewardship in an Outpatient Hemodialysis Unit N/A
Completed NCT03897231 - Prevalence of Non-adherence to Medication Among Patients on Chronic Hemodialysis
Withdrawn NCT03145662 - High Pressure Balloon vs Cutting Balloon N/A
Completed NCT02621918 - The Effects of Exercise in End-stage Renal Disease Patients Undergoing Hemodialysis N/A
Completed NCT01356615 - Low Molecular Weight Heparin for Hemodialysis Anticoagulation N/A
Terminated NCT01033357 - Safety Study of the Vascular Wrap Paclitaxel-Eluting Mesh for Hemodialysis Vascular Access N/A